Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients With Known/Newly Diagnosed Type I/Type II Diabetes Mellitus (DM) in Palliative Care/ Supportive Care (PC/SC) Setting.

NCT04942756 is registered in ClinicalTrials.gov with Antea Foundation as lead sponsor.

NCT NCT04942756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients With Known/Newly Diagnosed Type I/Type II Diabetes Mellitus (DM) in Palliative Care/ Supportive Care (PC/SC) Setting.
Lead sponsor
Antea Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2021
Completion date
June 30, 2022
Enrollment
118 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, cancer, diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2, end stage cancer, palliative care, terminal cancer, terminal illness